Home › Companies › Palisade Bio, Inc.
Palisade Bio, Inc. (PALI) proxy voting records
How asset managers voted at Palisade Bio, Inc.’s shareholder meetings, one page per
proxy season, compiled from the votes funds and managers report on SEC Form N-PX and
the company’s own results on Form 8-K.
- TickerPALI
- CUSIP issuer number696389
- SEC CIK1357459
Recent shareholder votes
- June 10, 2026 annual meeting (2025-2026 proxy season): 10 items in Palisade Bio, Inc.'s official results (Form 8-K, filed June 11, 2026); lowest support 70% of votes cast (Approval, on a non-binding advisory basis, of the compensation…). Full results and how funds voted.
- December 3, 2025 special meeting (2025-2026 proxy season): 3 items in Palisade Bio, Inc.'s official results (Form 8-K, filed December 4, 2025); lowest support 99.1% of votes cast (Approval of an Amendment to the Amended and Restated…). Full results and how funds voted.
- October 17, 2025 annual meeting (2025-2026 proxy season): 5 items in Palisade Bio, Inc.'s official results (Form 8-K, filed October 20, 2025); lowest support 68% of votes cast (Approval of an Amendment to the Amended and Restated…). Full results and how funds voted.
Each line is the company’s own Form 8-K tally as shown on that season’s page; support is FOR as a share of votes cast.
Proxy seasons
Explore Palisade Bio, Inc. in the interactive database
The seasons are grouped by the issuer number in the company’s CUSIP, not by
its name. Ticker as listed by the SEC on November 6, 2026.
This page is rebuilt weekly; built November 9, 2026.